Alliancebernstein L.P. Kezar Life Sciences, Inc. Transaction History
Alliancebernstein L.P.
- $275 Billion
- Q1 2024
A detailed history of Alliancebernstein L.P. transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 79,058 shares of KZR stock, worth $47,434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,058
Previous 79,058
-0.0%
Holding current value
$47,434
Previous $75,000
5.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding KZR
# of Institutions
86Shares Held
45MCall Options Held
2.6KPut Options Held
600-
Suvretta Capital Management, LLC New York, NY7.17MShares$4.3 Million0.28% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$3.02 Million0.17% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$2.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$1.86 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.05MShares$1.23 Million0.29% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $41M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...